Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of the polymorphism Y402H in the CFH gene with response to anti-VEGF treatment in age-related macular degeneration: a systematic review and meta-analysis
Authors
Keywords
-
Journal
ACTA OPHTHALMOLOGICA
Volume 94, Issue 4, Pages 334-345
Publisher
Wiley
Online
2016-05-06
DOI
10.1111/aos.13049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CFHpolymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration
- (2015) Montserrat García et al. ACTA OPHTHALMOLOGICA
- PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2015) Vaidehi S. Dedania et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: “real life” long-term outcome
- (2015) Gala Beykin et al. BMC Ophthalmology
- Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration
- (2014) Stefano Piermarocchi et al. ACTA OPHTHALMOLOGICA
- Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
- (2014) Freekje van Asten et al. OPHTHALMIC EPIDEMIOLOGY
- The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration
- (2014) Asta Hautamäki et al. OPHTHALMOLOGY
- Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration
- (2014) Wataru Matsumiya et al. PHARMACOGENOMICS
- Y402H Polymorphism in Complement Factor H and Age-Related Macular Degeneration in the Tunisian Population
- (2013) I. Habibi et al. OPHTHALMIC RESEARCH
- Genetic Association with Response to Intravitreal Ranibizumab for Neovascular Age-Related Macular Degeneration in the Han Chinese Population
- (2013) Dongqing Yuan et al. OPHTHALMOLOGICA
- Pharmacogenetic Associations with Vascular Endothelial Growth Factor Inhibition in Participants with Neovascular Age-related Macular Degeneration in the IVAN Study
- (2013) Andrew J. Lotery et al. OPHTHALMOLOGY
- Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
- (2013) Farshad Abedi et al. OPHTHALMOLOGY
- Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)
- (2013) Stephanie A. Hagstrom et al. OPHTHALMOLOGY
- INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2013) Asta Hautamäki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- GENETIC FACTORS ASSOCIATED WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB IN KOREAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Un Chul Park et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
- (2013) Justin Kanoff et al. Seminars in Ophthalmology
- Factors Associated With the Response of Age-Related Macular Degeneration to Intravitreal Ranibizumab Treatment
- (2012) Kenji Yamashiro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Age-related macular degeneration
- (2012) Laurence S Lim et al. LANCET
- Neovascular Age-Related Macular Degeneration
- (2012) Daniele Veritti et al. OPHTHALMOLOGICA
- Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration
- (2012) Dzenita Smailhodzic et al. OPHTHALMOLOGY
- Association of genetic polymorphisms with response to bevacizumab for neovascular age-related macular degeneration in the Chinese population
- (2012) Jun Tian et al. PHARMACOGENOMICS
- Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
- (2012) Moreno Menghini et al. PLoS One
- Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis
- (2012) Han Chen et al. PLoS One
- Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration
- (2011) Christian Nischler et al. ACTA OPHTHALMOLOGICA
- CFH,VEGFandHTRA1promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration
- (2011) Martin McKibbin et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION
- (2011) Anton Orlin et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Complement Factor H Y402H Variant and Risk of Age-Related Macular Degeneration in Asians: A Systematic Review and Meta-Analysis
- (2010) Naoshi Kondo et al. OPHTHALMOLOGY
- Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
- (2008) A Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Synthesis of genetic association studies for pertinent gene–disease associations requires appropriate methodological and statistical approaches
- (2008) Elias Zintzaras et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
- (2008) Salvatore Grisanti et al. PROGRESS IN RETINAL AND EYE RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started